ARBS — Arterra Bioscience SpA Cashflow Statement
0.000.00%
Last trade - 00:00- €14.95m
- €11.96m
- €4.17m
- 90
- 58
- 86
- 94
Annual cashflow statement for Arterra Bioscience SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1.11 | 1.11 | 1.41 | 1.08 | 1.34 |
| Depreciation | |||||
| Non-Cash Items | 0.111 | 0.276 | 0.729 | 0.389 | 0.532 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.14 | -0.477 | -1.28 | -0.972 | -1.14 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0.48 | 1.4 | 1.4 | 1.03 | 1.06 |
| Capital Expenditures | -0.383 | -0.609 | -0.099 | -0.083 | -0.665 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | -0.496 | -1.59 | -0.756 | -0.046 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.383 | -1.11 | -1.69 | -0.839 | -0.711 |
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.23 | -0.014 | -0.125 | -0.894 | -0.696 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.133 | 0.278 | -0.421 | -0.707 | -0.342 |